Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Background: Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) is characterised by severe prolonged fatigue, and decreases in cognition and other physiological functions, resulting in severe loss of quality of life, difficult clinical management and high costs to the health care system. To date there is no proven pathomechanism to satisfactorily explain this disorder. Studies have identified abnormalities in immune function but these data are inconsistent. We investigated the profile of markers of immune function (including novel markers) in CFS/ME patients. Methods: We included 95 CFS/ME patients and 50 healthy controls. All participants were assessed on natural killer (NK) and CD8+T cell cytotoxic activities, Th1 and Th2 cytokine profile of CD4+T cells, expression of vasoactive intestinal peptide receptor 2 (VPACR2), levels of NK phenotypes (CD56 bright and CD56 dim) and regulatory T cells expressing FoxP3 transcription factor. Results: Compared to healthy individuals, CFS/ME patients displayed significant increases in IL-10, IFN-γ, TNF-α, CD4+CD25+T cells, FoxP3 and VPACR2 expression. Cytotoxic activity of NK and CD8+T cells and NK phenotypes, in particular the CD56 bright NK cells were significantly decreased in CFS/ME patients. Additionally granzyme A and granzyme K expression were reduced while expression levels of perforin were significantly increased in the CFS/ME population relative to the control population. These data suggest significant dysregulation of the immune system in CFS/ME patients. Conclusions: Our study found immunological abnormalities which may serve as biomarkers in CFS/ME patients with potential for an application as a diagnostic tool.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study
Fukuda, K., Straus, S. E., Hickie, I., Sharpe, M. C., Dobbins, J. G., Komaroff, A., & and International Chronic Fatigue Syndrome Study Group. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-12-199412150-00009 · Cited by 4,969 · cited 2×
“Prior to inclusion all participants completed a consent form and a Chronic Fatigue Syndrome questionnaire based on the Centre for Disease Prevention and Control case definition (CDC 1994) [ 4 ].”
BackgroundMethodIL-10: The Master Regulator of Immunity to Infection
Couper, K. N., Blount, D. G., & Riley, E. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.5771 · Cited by 2,223 · cited 1×
“Nonetheless, increased levels of IL-10, IFN-g and TNF-a indicate the presence of fungal, bacterial or viral infection [37].”
BackgroundCD4 T cells: fates, functions, and faults
Zhu, J., & Paul, W. E. (2008) · Blood · doi:10.1182/blood-2008-05-078154 · Cited by 1,798 · cited 1×
“Th1 cells secrete cytokines IFN-g and IL-2 while Th2 cells secrete cytokines IL-4 and IL-10 [32] and Th17 secrete pro-inflammatory IL-17a, IL-17f and IL-22 [33,34].”
BackgroundHuman natural killer cells: a unique innate immunoregulatory role for the CD56bright subset
Cooper, M. A., Fehniger, T. A., Turner, S. C., Chen, K. S., Ghaheri, B. A., Ghayur, T., Carson, W. E., & Caligiuri, M. A. (2001) · Blood · doi:10.1182/blood.v97.10.3146 · Cited by 1,449 · cited 1×
“Quantification of NK Phenotypes Distribution of NK cell phenotypes was assessed as previously described [ 23 ].”
MethodPrins, J. B., van der Meer, J. W., & Bleijenberg, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68073-2 · Cited by 974
Death by a Thousand Cuts: Granzyme Pathways of Programmed Cell Death
Chowdhury, D., & Lieberman, J. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090404 · Cited by 700 · cited 1×
“Perforin forms pore-like structures to facilitate the entry of granzymes into the target cell [50], and granzymes activate several apoptosis pathways that ensure effective killing of the target cell [51].”
BackgroundChronically Inflamed Human Tissues Are Infiltrated by Highly Differentiated Th17 Lymphocytes
Pène, J., Chevalier, S., Preisser, L., Vénéreau, E., Guilleux, M.-H., Ghannam, S., Molès, J.-P., Danger, Y., Ravon, E., Lesaux, S., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7423 · Cited by 527 · cited 1×
“Th1 cells secrete cytokines IFN-g and IL-2 while Th2 cells secrete cytokines IL-4 and IL-10 [32] and Th17 secrete pro-inflammatory IL-17a, IL-17f and IL-22 [33,34].”
BackgroundImmunologic abnormalities in chronic fatigue syndrome
Klimas, N. G., Salvato, F. R., Morgan, R., & Fletcher, M. A. (1990) · Journal of Clinical Microbiology · doi:10.1128/jcm.28.6.1403-1410.1990 · Cited by 464 · cited 1×
“Decreased function of lymphocytes, in particular Natural Killer (NK) cell cytotoxic activity in CFS/ME patients compared to healthy controls, seems to be a consistent finding [13-16].”
BackgroundSelf-citationImmunological aspects of chronic fatigue syndrome
Lorusso, L., Mikhaylova, S. V., Capelli, E., Ferrari, D., Ngonga, G. K., & Ricevuti, G. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.08.003 · Cited by 277 · cited 2×
“Population based studies have suggested a link between infections, neurological and neuroimmune dysfunctions and clinical manifestations of CFS/ME [5-10].”
Background(2020) · Nursing Management · doi:10.1097/01.numa.0000719220.85627.ef · Cited by 276
The IL-23/Th17 Axis Contributes to Renal Injury in Experimental Glomerulonephritis
Paust, H.-J., Turner, J.-E., Steinmetz, O. M., Peters, A., Heymann, F., Ho[Combining Diaeresis]lscher, C., Wolf, G., Kurts, C., Mittru[Combining Diaeresis]cker, H.-W., Stahl, R. A. K., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008050556 · Cited by 245 · cited 1×
“Th1 cells secrete cytokines IFN-g and IL-2 while Th2 cells secrete cytokines IL-4 and IL-10 [32] and Th17 secrete pro-inflammatory IL-17a, IL-17f and IL-22 [33,34].”
BackgroundAnnexin V used for measuring apoptosis in the early events of cellular cytotoxicity
Aubry, J., Blaecke, A., Lecoanet-Henchoz, S., Jeannin, P., Herbault, N., Caron, G., Moine, V., & Bonnefoy, J. (1999) · Cytometry · doi:10.1002/(sici)1097-0320(19991101)37:3<197::aid-cyto6>3.0.co;2-l · Cited by 243 · cited 2×
“NK lymphocyte cytotoxic activity was performed as previously described [21].”
MethodA formal analysis of cytokine networks in chronic fatigue syndrome
Broderick, G., Fuite, J., Kreitz, A., Vernon, S. D., Klimas, N., & Fletcher, M. A. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.04.012 · Cited by 202 · cited 3×
“However, newer and more sensitive assays have been developed since the conflicting results were reported [17].”
BackgroundResultSelf-citationDelgado, M., Munoz-Elias, E. J., Gomariz, R. P., & Ganea, D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1707 · Cited by 201 · cited 1×
“The changes in both the Th1 and Th2 responses may suggest changes in the function of VN receptor VPACR2 which is a key promoter and stimulator of anti-inflammatory cytokines such as IL-10 [44].”
BackgroundEvidence of Systemic Th2-Driven Chronic Inflammation in Patients with Metastatic Melanoma
Nevala, W. K., Vachon, C. M., Leontovich, A. A., Scott, C. G., Thompson, M. A., Markovic, S. N., & for the Melanoma Study Group of the Mayo Clinic Cancer Center (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1980 · Cited by 178 · cited 1×
“A predominant Th1 and Th17 immune response has been linked to the development or presence of an autoimmune disease whereas increases in Th2 cytokines suggest the presence of other systemic disorders [30, 31 ].”
BackgroundPlasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity
Scully, P., McKernan, D. P., Keohane, J., Groeger, D., Shanahan, F., Dinan, T. G., & Quigley, E. M. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.159 · Cited by 176 · cited 1×
“cytokines such as TNF-a, may also depict the presence of an inflamed gut or irritable bowel syndrome in some CFS/ME patients [ 41 ].”
BackgroundThe Economic impact of ME/CFS: Individual and societal costs
Jason, L. A., Benton, M. C., Valentine, L., Johnson, A., & Torres-Harding, S. (2008) · Dynamic Medicine · doi:10.1186/1476-5918-7-6 · Cited by 174 · cited 2×
“The annual cost for treatment and management of CFS/ME in the USA is estimated to be US$319 million with a direct cost of US$7,406 per patient [3].”
BackgroundDevanur, L. D., & Kerr, J. R. (2006) · Journal of Clinical Virology · doi:10.1016/j.jcv.2006.08.013 · Cited by 174
Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome
Kaushik, N. K., Fear, D. J., Richards, S., McDermott, C., Nuwaysir, E. F., Kellam, P., Harrison, T. J., Wilkinson, R., Tyrrell, D. A. J., Holgate, S. T., et al. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.025718 · Cited by 161 · cited 1×
“Others have shown that IL-10RA is differentially expressed in CFS/ME patients, highlighting a potential compromise in IL-10 function or its receptor in CFS/ME patients [35,36].”
BackgroundEtiology of fibromyalgia: The possible role of infection and vaccination
Buskila, D., Atzeni, F., & Sarzi‐Puttini, P. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.07.023 · Cited by 147 · cited 1×
“While levels of viral antigens were not measured in this study, these observations may suggest a plausible prevalence in viral antigens, adjuvants or autoantibodies in the peripheral circulation of CFS/ME patients [48,49].”
BackgroundGut inflammation in chronic fatigue syndrome
Lakhan, S. E., & Kirchgessner, A. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-79 · Cited by 143 · cited 1×
“Population based studies have suggested a link between infections, neurological and neuroimmune dysfunctions and clinical manifestations of CFS/ME [5-10].”
BackgroundElevations in IL-10, TNF- α , and IFN- γ from the Earliest Point of HIV Type 1 Infection
Norris, P. J., Pappalardo, B. L., Custer, B., Spotts, G. E., Hecht, F. M., & Busch, M. P. (2006) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2006.22.757 · Cited by 131
White, L., Krishnan, S., Štrbo, N., Liu, H., Kolber, M. A., Lichtenheld, M. G., Pahwa, R. N., & Pahwa, S. G. (2006) · Blood · doi:10.1182/blood-2006-09-045278 · Cited by 129 · cited 3×
“and may be associated with a dampening of the NK and CD8T cell immune response [22].”
BackgroundMethodInfluentialGoehler, L. E., Lyte, M., & Gaykema, R. P. A. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.02.005 · Cited by 127 · cited 1×
“Inflammation in the gut can alter the central nervous system [42,43] and affects various physiological mechanisms including neuropeptides.”
BackgroundFletcher, M. A., Zeng, X. R., Maher, K., Levis, S., Hurwitz, B., Antoni, M., Broderick, G., & Klimas, N. G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010817 · Cited by 127 · cited 1×
“Decreased function of lymphocytes, in particular Natural Killer (NK) cell cytotoxic activity in CFS/ME patients compared to healthy controls, seems to be a consistent finding [13-16].”
BackgroundSelf-citationHigh levels of type 2 cytokine-producing cells in chronic fatigue syndrome
SKOWERA, A., CLEARE, A., BLAIR, D., BEVIS, L., WESSELY, S. C., & PEAKMAN, M. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02354.x · Cited by 123 · cited 1×
“It has been suggested that the mechanism underlying CFS/ME may involve a shift in cytokine production leading to either a predominant Th1 or Th2 cytokine profile [27-29].”
BackgroundVIP–PACAP System in Immunity: New Insights for Multitarget Therapy
Gomariz, R. P., Juarranz, Y., Abad, C., Arranz, A., Leceta, J., & Martinez, C. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1317.031 · Cited by 123
Immune and hemorheological changes in Chronic Fatigue Syndrome
Brenu, E., Staines, D., Baskurt, O. K., Ashton, K. J., Ramos, S. B., Christy, R., & Marshall‐Gradisnik, S. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-1 · Cited by 119 · cited 2×
“Decreased function of lymphocytes, in particular Natural Killer (NK) cell cytotoxic activity in CFS/ME patients compared to healthy controls, seems to be a consistent finding [13-16].”
BackgroundResultSelf-citationSchutzer, S. E., Angel, T. E., Liu, T., Schepmoes, A. A., Clauss, T. R., Adkins, J. N., Camp, D. G., Holland, B. K., Bergquist, J., Coyle, P. K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017287 · Cited by 117 · cited 1×
“Population based studies have suggested a link between infections, neurological and neuroimmune dysfunctions and clinical manifestations of CFS/ME [5-10].”
BackgroundChronic fatigue syndrome is associated with diminished intracellular perforin
Maher, K. J., Klimas, N. G., & Fletcher, M. A. (2005) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02935.x · Cited by 116 · cited 2×
“Decreased function of lymphocytes, in particular Natural Killer (NK) cell cytotoxic activity in CFS/ME patients compared to healthy controls, seems to be a consistent finding [13-16].”
BackgroundSelf-citationImmunobiology of vasoactive intestinal peptide (VIP)
Pozo, D., Delgado, M., Martı́nez, C., Guerrero, J. M., Leceta, J., Gomariz, R. P., & Calvo, J. R. (2000) · Immunology Today · doi:10.1016/s0167-5699(99)01525-x · Cited by 113 · cited 1×
“These important neuropeptides increase IL-10 gene expression via the cAMP response element DNA binding complex pathway, therefore changes in VNs such as elevations in VPACR2 may suggest an increase in IL-10 [45].”
BackgroundSpinal Fluid Abnormalities in Patients with Chronic Fatigue Syndrome
Natelson, B. H., Weaver, S. A., Tseng, C.-L., & Ottenweller, J. E. (2005) · Clinical and Vaccine Immunology · doi:10.1128/cdli.12.1.52-55.2005 · Cited by 113 · cited 1×
“Population based studies have suggested a link between infections, neurological and neuroimmune dysfunctions and clinical manifestations of CFS/ME [5-10].”
BackgroundCerebral blood flow is reduced in chronic fatigue syndrome as assessed by arterial spin labeling
Biswal, B., Kunwar, P., & Natelson, B. H. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.11.018 · Cited by 105 · cited 1×
“Population based studies have suggested a link between infections, neurological and neuroimmune dysfunctions and clinical manifestations of CFS/ME [5-10].”
BackgroundNancy, A., & Shoenfeld, Y. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.07.026 · Cited by 97 · cited 1×
“While levels of viral antigens were not measured in this study, these observations may suggest a plausible prevalence in viral antigens, adjuvants or autoantibodies in the peripheral circulation of CFS/ME patients [48,49].”
BackgroundThe many faces of VIP in neuroimmunology: a cytokine rather a neuropeptide?
Pozo, D., & Delgado, M. (2004) · The FASEB Journal · doi:10.1096/fj.03-1440hyp · Cited by 91 · cited 1×
“Further, an increase in TNF-a and IFN-g suggests an inability of the heightened VPACR2 to suppress TNF-a and IFN-g secretion as these neuropeptides are noted to suppress pro-inflammatory cytokines while favouring anti-inflammatory cytokine secretions [46].”
BackgroundLymphocyte Subsets, Apoptosis, and Cytokines in Patients with Chronic Fatigue Syndrome
Swanink, C. M. A., Vercoulen, J. H. M. M., Galama, J. M. D., Roos, M. T. L., Meyaard, L., van der Ven-Jongekrijg, J., de Nijs, R., Bleijenberg, G., Fennis, J. F. M., Miedema, F., et al. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/173.2.460 · Cited by 91 · cited 1×
“It has been suggested that the mechanism underlying CFS/ME may involve a shift in cytokine production leading to either a predominant Th1 or Th2 cytokine profile [27-29].”
BackgroundGonzález‐Rey, E., & Delgado, M. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.04.003 · Cited by 82 · cited 7×
“This is the first study to show significantly higher levels of VPACR2 receptors, CD4 + CD25 + Tregs and FoxP3 + Treg expression in CFS/ME patients compared to healthy controls.”
BackgroundInfluentialSzkaradkiewicz, A., Karpiński, T. M. M., Drews, M., Borejsza‐Wysocki, M., Majewski, P., & Andrzejewska, E. (2010) · BioMed Research International · doi:10.1155/2010/901564 · Cited by 76 · cited 1×
“An increase in IL-10 also may contribute to decreased cytotoxic activity observed in the NK and CD8T cells [39,40].”
Backgroundden Haan, J. M. M., Kraal, G., & Bevan, M. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5429 · Cited by 72 · cited 1×
“An increase in IL-10 also may contribute to decreased cytotoxic activity observed in the NK and CD8T cells [39,40].”
Identification of Marker Genes for Differential Diagnosis of Chronic Fatigue Syndrome
Saiki, T., Kawai, T., Morita, K., Ohta, M., Saito, T., Rokutan, K., & Ban, N. (2008) · Molecular Medicine · doi:10.2119/2007-00059.saiki · Cited by 64
Cytokines across the Night in Chronic Fatigue Syndrome with and without Fibromyalgia
Nakamura, T., Schwander, S. K., Donnelly, R., Ortega, F., Togo, F., Broderick, G., Yamamoto, Y., Cherniack, N. S., Rapoport, D., & Natelson, B. H. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00379-09 · Cited by 57 · cited 1×
“It has been suggested that the mechanism underlying CFS/ME may involve a shift in cytokine production leading to either a predominant Th1 or Th2 cytokine profile [27-29].”
BackgroundSun, W., Hong, J., Zang, Y. C. Q., Liu, X., & Zhang, J. (2006) · International Immunology · doi:10.1093/intimm/dxl103 · Cited by 52 · cited 13×
“The changes in both the Th1 and Th2 responses may suggest changes in the function of VN receptor VPACR2 which is a key promoter and stimulator of anti-inflammatory cytokines such as IL-10 [44].”
MethodInfluentialTranscriptional Control of Complement Activation in an Exercise Model of Chronic Fatigue Syndrome
Sorensen, B., Jones, J. F., Vernon, S. D., & Rajeevan, M. S. (2009) · Molecular Medicine · doi:10.2119/molmed.2008.00098 · Cited by 47 · cited 1×
“Nonetheless, findings on immunoglobulins, complement markers and activation molecules in CFS/ ME, may demonstrate an underlying infringement in immune function [8,11,12].”
BackgroundChronic fatigue syndrome – A neuroimmunological model
Arnett, S., Alleva, L. M., Korossy-Horwood, R., & Clark, I. A. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.03.030 · Cited by 46 · cited 1×
“Population based studies have suggested a link between infections, neurological and neuroimmune dysfunctions and clinical manifestations of CFS/ME [5-10].”
BackgroundNijs, J., Eupen, I. V., Vandecauter, J., Augustinus, E., Bleyen, G., Moorkens, G. H., & Meeus, M. (2009) · The Journal of Rehabilitation Research and Development · doi:10.1682/jrrd.2009.01.0007 · Cited by 43 · cited 1×
“Nonetheless, findings on immunoglobulins, complement markers and activation molecules in CFS/ ME, may demonstrate an underlying infringement in immune function [8,11,12].”
BackgroundDrulovic, J. S., Savić, E., Pekmezovic, T. D., Mesaroš, Š., Stojsavljević, N., Dujmović, I., Kostić, J., Vasić, V., Stojković, M. M., & Popadic, D. M. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.07.010 · Cited by 38 · cited 1×
“A predominant Th1 and Th17 immune response has been linked to the development or presence of an autoimmune disease whereas increases in Th2 cytokines suggest the presence of other systemic disorders [ 30 ,31].”
Gene profiling of patients with chronic fatigue syndrome/myalgic encephalomyelitis
Kerr, J. R. (2008) · Current Rheumatology Reports · doi:10.1007/s11926-008-0079-5 · Cited by 24 · cited 1×
“Others have shown that IL-10RA is differentially expressed in CFS/ME patients, highlighting a potential compromise in IL-10 function or its receptor in CFS/ME patients [35,36].”
BackgroundOkwor, I., Muleme, H. M., Jia, P., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/599792 · Cited by 14 · cited 1×
“PBMC Cells were stained with monoclonal antibodies FITC-CD4 and APC-CD25 (BD Pharmingen, San Diego, CA) following which cells were permeablised and stained with anti-FoxP3 and PE-Foxp3 respectively and analysed via flow cytometery [26].”
MethodIs chronic fatigue syndrome caused by a rare brain infection of a common, normally benign virus?
Grinde, B. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2008.03.014 · Cited by 13 · cited 1×
“5% [1] with a higher prevalence in females compared to males, at a ratio of up to 6:1 [2].”
BackgroundProfiling killers; unravelling the pathways of human natural killer cell function
Scott, G. B., Meade, J. L., & Cook, G. P. (2008) · Briefings in Functional Genomics and Proteomics · doi:10.1093/bfgp/elm037 · Cited by 7 · cited 1×
“Perforin forms pore-like structures to facilitate the entry of granzymes into the target cell [50], and granzymes activate several apoptosis pathways that ensure effective killing of the target cell [51].”
Background
Cited by
Human CD56bright NK Cells: An Update
Michel, T., Poli, A., Cuapio, A., Briquemont, B., Iserentant, G., Ollert, M., & Zimmer, J. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502570 · Cited by 395
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome – Evidence for an autoimmune disease
Sotzny, F., Blanco, J., Capelli, E., Castro-Marrero, J., Steiner, S., Murovska, M., & Scheibenbogen, C. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.01.009 · Cited by 272
Distinct plasma immune signatures in ME/CFS are present early in the course of illness
Hornig, M., Montoya, J. G., Klimas, N. G., Levine, S., Felsenstein, D., Bateman, L., Peterson, D. L., Gottschalk, C. G., Schultz, A. F., Che, X., et al. (2015) · Science Advances · doi:10.1126/sciadv.1400121 · Cited by 263
Self-citationThe many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
Morris, G., & Berk, M. (2015) · BMC Medicine · doi:10.1186/s12916-015-0310-y · Cited by 245
“Elevated levels of TNF-α and IL-1β are, in fact, particularly commonplace observations in patients recruited into studies using the internationally agreed diagnostic guidelines [202,205-211].”
BackgroundLoebel, M., Grabowski, P., Heidecke, H., Bauer, S., Hanitsch, L. G., Wittke, K., Meisel, C., Reinke, P., Volk, H.-D., Fluge, Ø., et al. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.09.013 · Cited by 244
Metadata
- Authors
- Brenu, E. W., van Driel, M. L., Staines, D. R., Ashton, K. J., Ramos, S. B., Keane, J., Klimas, N. G., & Marshall-Gradisnik, S. M.
- Venue
- Journal of Translational Medicine
- Published
- 2011-05-28
- Volume
- 9
- Issue
- 1
- Pages
- 81-81
- ISSN
- 1479-5876 (ISSN-L)
- OpenAlex
- W2118518863
- Cited by
- 251
- References
- 50
- FWCI
- 11.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.